ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

FEMY Femasys Inc

1,27
0,00 (0,00%)
Vor Marktöffnung
Zuletzt aktualisiert: 10:16:46
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Femasys Inc FEMY NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,00 0,00% 1,27 10:16:46
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
1,27
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
18.4.202414:30GLOBEFemasys CEO and Founder Kathy Lee-Sepsick Meets with Members..
28.3.202421:05GLOBEFemasys Announces Financial Results for Year Ended December..
21.3.202414:00GLOBEFemasys Invites Investors to View Fireside Chat Today, March..
20.3.202413:15GLOBEFemasys Announces Positive Topline Data from Pivotal Trial..
13.3.202414:00GLOBEFemasys to Participate in Fireside Chat to Discuss the..
06.3.202415:09EDGAR2Form 8-K - Current report
06.3.202415:00GLOBEFemasys Completes the First In-Office Commercial Procedure..
28.2.202415:16EDGAR2Form 8-K - Current report
14.2.202403:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.2.202403:44EDGAR2Form 3 - Initial statement of beneficial ownership of..
06.2.202414:47EDGAR2Form 8-K - Current report
02.2.202422:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.2.202422:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.2.202422:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.12.202306:15EDGAR2Form EFFECT - Notice of Effectiveness
08.12.202315:28EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
30.11.202323:17EDGAR2Form S-3 - Registration statement under Securities Act of..
29.11.202322:05EDGAR2Form 8-K - Current report
22.11.202322:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.11.202322:33EDGAR2Form 3 - Initial statement of beneficial ownership of..
21.11.202323:30EDGAR2Form 8-K - Current report
15.11.202323:19EDGAR2Form 8-K - Current report
15.11.202314:30BWPharmaCyte Biotech Acquires $5 Million Stake in Emerging..
02.11.202302:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.10.202314:01EDGAR2Form 8-K - Current report
03.10.202315:28EDGAR2Form 8-K - Current report
03.10.202315:27EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
27.9.202314:19EDGAR2Form 8-K - Current report
06.9.202323:00EDGAR2Form 8-K - Current report
10.8.202314:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10.8.202314:05EDGAR2Form 8-K - Current report
07.8.202314:40EDGAR2Form DEF 14A - Other definitive proxy statements
03.8.202315:04EDGAR2Form 8-K - Current report
28.7.202323:15EDGAR2Form PRE 14A - Other preliminary proxy statements
27.7.202315:04EDGAR2Form 8-K - Current report
14.7.202322:16EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
07.7.202322:26EDGAR2Form S-1/A - General form for registration of securities..
04.7.202300:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.7.202300:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock